- Home
- PBYI
as 07-26-2024 4:00pm EST
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Upcoming Earnings Alert:
Get ready for potential market movements as Puma Biotechnology Inc PBYI prepares to release earnings report on 01 Aug 2024.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | LOS ANGELES |
| Market Cap: | 144.2M | IPO Year: | N/A |
| Target Price: | $7.00 | AVG Volume (30 days): | 632.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.32 | EPS Growth: | 220.00 |
| 52 Week Low/High: | $2.13 - $7.73 | Next Earning Date: | 08-01-2024 |
| Revenue: | $226,628,000 | Revenue Growth: | -3.59% |
| Revenue Growth (this year): | -5.35% | Revenue Growth (next year): | -3.04% |
Stock Insider Trading Activity of Puma Biotechnology Inc (PBYI)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| AUERBACH ALAN H | PBYI | President and CEO | Jul 17 '24 | Sell | $3.70 | 21,920 | $81,128.11 | 7,063,515 | SEC Form 4 |
| HUNT DOUGLAS M | PBYI | See Remarks | Jul 2 '24 | Sell | $3.27 | 4,349 | $14,214.71 | 136,864 | SEC Form 4 |
| NOUGUES MAXIMO F | PBYI | Chief Financial Officer | Jul 2 '24 | Sell | $3.27 | 5,295 | $17,306.71 | 166,678 | SEC Form 4 |
| Ludwig Jeffrey Jerome | PBYI | Chief Commercial Officer | Jul 2 '24 | Sell | $3.27 | 6,051 | $19,777.69 | 120,986 | SEC Form 4 |
| WILSON TROY EDWARD | PBYI | Director | Jun 13 '24 | Sell | $3.33 | 27,000 | $89,901.90 | 350 | SEC Form 4 |
| MOYES JAY M | PBYI | Director | Jun 13 '24 | Sell | $3.34 | 22,000 | $73,466.80 | 21,322 | SEC Form 4 |
| Dorval Allison | PBYI | Director | Jun 13 '24 | Sell | $3.37 | 11,000 | $37,096.40 | 33,000 | SEC Form 4 |
| Stuglik Brian M | PBYI | Director | Jun 13 '24 | Sell | $3.39 | 9,900 | $33,528.33 | 49,058 | SEC Form 4 |
| Senderowicz Adrian | PBYI | Director | Jun 13 '24 | Sell | $3.33 | 27,000 | $89,818.20 | 0 | SEC Form 4 |
| Wong Alvin F | PBYI | Chief Scientific Officer | Jan 3 '24 | Sell | $4.49 | 7,733 | $34,689.46 | 98,214 | SEC Form 4 |
| HUNT DOUGLAS M | PBYI | See Remarks | Jan 3 '24 | Sell | $4.49 | 8,358 | $37,493.15 | 103,319 | SEC Form 4 |
| NOUGUES MAXIMO F | PBYI | Chief Financial Officer | Jan 3 '24 | Sell | $4.49 | 15,682 | $70,347.88 | 128,666 | SEC Form 4 |
| Ludwig Jeffrey Jerome | PBYI | Chief Commercial Officer | Jan 3 '24 | Sell | $4.49 | 12,956 | $58,119.32 | 99,970 | SEC Form 4 |
| AUERBACH ALAN H | PBYI | President and CEO | Jan 3 '24 | Sell | $4.49 | 41,396 | $185,698.32 | 6,936,947 | SEC Form 4 |
| Wong Alvin F | PBYI | Chief Scientific Officer | Dec 4 '23 | Sell | $3.76 | 280 | $1,053.02 | 97,934 | SEC Form 4 |
| MILLER MICHAEL PATRICK | PBYI | Director | Nov 7 '23 | Sell | $2.83 | 25,000 | $70,802.50 | 43,358 | SEC Form 4 |
Latest Puma Biotechnology Inc News
PBYI Breaking Stock News: Dive into PBYI Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Should Value Investors Buy Puma Biotechnology (PBYI) Stock?
Business Wire
8 days ago
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results
Business Wire
24 days ago
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
GOBankingRates
2 months ago
5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
AFP
2 months ago
Bumrah delivers as India beat Pakistan in low-scoring thriller
AFP
2 months ago
Italy beat Bosnia in final Euros warm-up
Bloomberg
2 months ago
Macron Calls French Legislative Election After Far-Right Surge
AFP
2 months ago
Trump loyalists proud to support 'felon' at Las Vegas rally
Compare PBYI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PBYI Puma Biotechnology Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.